These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1461951)

  • 21. A revised interpretation of postdexamethasone ACTH and cortisol findings in unipolar depressed females.
    Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Blockx P
    Psychiatry Res; 1990 Nov; 34(2):107-26. PubMed ID: 1962860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Habituation and cortisol dysregulation in depression.
    Reus VI; Peeke HV; Miner C
    Biol Psychiatry; 1985 Sep; 20(9):980-9. PubMed ID: 4027316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age and gender effects on the diagnostic power of the DST.
    Ansseau M; Depauw Y; Charles G; Castro P; D'Haenen H; De Vigne JP; Hubain P; Legros JJ; Pelc I; Toscano A
    J Affect Disord; 1987; 12(3):185-91. PubMed ID: 2956303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT; Poland RE; Lesser IM; Winston RA; Blodgett AL
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
    Hudson JI; Pope HG; Jonas JM; Laffer PS; Hudson MS; Melby JC
    Psychiatry Res; 1983 Feb; 8(2):111-7. PubMed ID: 6574529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dexamethasone suppression test: interaction of diagnosis, sex, and age in psychiatric inpatients.
    Nelson WH; Khan A; Orr WW; Tamragouri RN
    Biol Psychiatry; 1984 Sep; 19(9):1293-304. PubMed ID: 6498252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple depressive episodes and plasma postdexamethasone cortisol levels.
    Meador-Woodruff JH; Gurguis G; Grunhaus L; Haskett RF; Greden JF
    Biol Psychiatry; 1987 May; 22(5):583-92. PubMed ID: 3580433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression.
    Roy A
    Biol Psychiatry; 1992 Nov; 32(9):812-6. PubMed ID: 1450295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemistry and suicidal behavior in depressed patients.
    Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis J; Maas JW; Landis H
    Biol Psychiatry; 1986 Jul; 21(8-9):756-67. PubMed ID: 3730460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of high concentrations of postdexamethasone cortisol in elderly psychiatric inpatients.
    Fogel BS; Satel SL; Levy S
    Psychiatry Res; 1985 Jun; 15(2):85-90. PubMed ID: 3862149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of abnormal dexamethasone suppression test in alcoholics abstinent for four weeks.
    Del Porto JA; Monteiro MG; Laranjeira RR; Jorge MR; Masur J
    Biol Psychiatry; 1985 Nov; 20(11):1156-60. PubMed ID: 4052517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced adrenal sensitivity to exogenous cosyntropin (ACTH alpha 1-24) stimulation in major depression. Relationship to dexamethasone suppression test results.
    Jaeckle RS; Kathol RG; Lopez JF; Meller WH; Krummel SJ
    Arch Gen Psychiatry; 1987 Mar; 44(3):233-40. PubMed ID: 3030218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone suppression test in geriatric depression.
    Alexopoulos GS; Young RC; Kocsis JH; Brockner N; Butler TA; Stokes PE
    Biol Psychiatry; 1984 Nov; 19(11):1567-71. PubMed ID: 6518207
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract]   [Full Text] [Related]  

  • 40. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
    Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
    Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.